MedTrace Logo

Integrated Telemonitoring and Nurse Support Evaluation

NCT01700218 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 350

Last updated 2014-11-25

No results posted yet for this study

Summary

The purpose of the study is to test a new medical device for optimizing treatment of heart failure and compare its effect on outcome of patients with a recent hospitalization for worsening heart failure

Conditions

Interventions

OTHER

telemonitoring

OTHER

control

Sponsors & Collaborators

  • Ludwig Boltzmann Institute for translational heart failure research

    collaborator UNKNOWN

  • AIT Austrian Institute of Technology GmbH

    collaborator OTHER

  • Medical University of Graz

    lead OTHER

Principal Investigators

  • Friedrich M Fruhwald, MD · Medical University of Graz

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-10-31
Primary Completion
2015-04-30
Completion
2015-10-31

Countries

  • Austria

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01700218 on ClinicalTrials.gov